APA aipamena

Lozenski, K., Kish-Catalone, T., Pirrone, V., Rando, R. F., Labib, M., Wigdahl, B., & Krebs, F. C. (2011). Cervicovaginal Safety of the Formulated, Biguanide-Based Human Immunodeficiency Virus Type 1 (HIV-1) Inhibitor NB325 in a Murine Model. Hindawi Publishing Corporation.

Chicago Style aipamena

Lozenski, Karissa, Tina Kish-Catalone, Vanessa Pirrone, Robert F. Rando, Mohamed Labib, Brian Wigdahl, and Fred C. Krebs. Cervicovaginal Safety of the Formulated, Biguanide-Based Human Immunodeficiency Virus Type 1 (HIV-1) Inhibitor NB325 in a Murine Model. Hindawi Publishing Corporation, 2011.

MLA aipamena

Lozenski, Karissa, et al. Cervicovaginal Safety of the Formulated, Biguanide-Based Human Immunodeficiency Virus Type 1 (HIV-1) Inhibitor NB325 in a Murine Model. Hindawi Publishing Corporation, 2011.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.